Figure 3: The general steps and common time frame for drug development

Uploaded by U.S. Government Accountability Office
License United States Government Work
Comments 0
Favorites 1
Views 5,039
Date uploaded 2025-06-18
Tags gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, humanorganonachip, gao25107335, 3d, threedimensional, darpa, defenseadvancedresearchprojectsagency, dod, departmentofdefense, epa, environmentalprotectionagency, fda, usfoodanddrugadministration, iccvam, interagencycoordinatingcommitteeonthevalidationofalternativemethods, iso, internationalorganizationforstandardization, istand, fdasinnovativescienceandtechnologyapproachesfornewdrugspilotprogram, ncats, nationalcenterforadvancingtranslationalsciences, nih, nationalinstitutesofhealth, nist, nationalinstituteofstandardsandtechnology, ooc, organonachip, oecd, organisationforeconomiccooperationanddevelopment, texval, texasamtissuechipvalidationconsortium
Visibility public